Powder: -20°C for 3 years | In solvent: -80°C for 2 years
XC-302 is a multi-targeted inhibitor, it induces Autophagy of nasopharyngeal cancer cells via inhibiting the PI3K/Akt/mTOR signaling pathway.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 970.00
$ 776.00
|
|
50 mg | 6-8 weeks | $ 1,980.00
$ 1,584.00
|
|
100 mg | 6-8 weeks | $ 2,500.00
$ 2,000.00
|
Description | XC-302 is a multi-targeted inhibitor, it induces autophagy of nasopharyngeal cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway. |
Synonyms | XC-302, Puquitinib, XC 302, XC302 |
Molecular Weight | 317.35 |
Formula | C17H15N7 |
CAS No. | 916890-10-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
XC-302 free base 916890-10-3 XC-302 Puquitinib XC 302 XC 302 free base XC302 XC302 free base inhibitor inhibit